Enovis (ENOV) Return on Equity ROE from the second quarter 2026 to second quarter 2025 and annually, average high and low, overall ranking from Jul 03 2026 to Jul 04 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Enovis Corp  (NYSE: ENOV)

Enovis's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Enovis in the second quarter 2026?
Enovis Corp had a negative return on equity (ROE) of -68.01%, due to the net loss of $-1 billion, during the twelve months ending in the second quarter 2026.

Within the Medical Equipment & Supplies industry 112 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the first quarter 2026 from 3253 to 3289.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Jul 03 2026)
II. Quarter		 (Apr 03 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Oct 03 2025)
III. Quarter		 (Jul 04 2025)
II. Quarter
Y / Y Equity Change -42.69 % -43.54 % -41.82 % -39.29 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -1,101 -1,136 -1,184 -1,366 -827
Return On Equity (TTM) -68.01 % -60 % -54.31 % -55.83 % -29.79 %
ENOV's Total Ranking # 3289 # 3253 # 1968 # 2918 # 2345
Equity (TTM) in Millions 1,479 1,479 1,492 2,024 2,581
Seq. Equity Change -0.02 % -0.83 % -26.28 % -21.59 % -1.5 %
Seq. Net Income Change - - - - -

Back to ENOV Management Effectiveness >> ENOV's 5 Years Annual ROE >> Compare ENOV ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 113
Sector # 453
Overall # 3289

Return On Equity Statistics
High Average Low
12.23 %
-3.25 %
-60 %
(Mar 27 2015)   (Apr 03 2026)





ENOV Annual Return On Equity (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Equity in Millions 1,492 2,564 3,421 3,450 4,661
Y / Y Equity Change -41.82 % -25.03 % -0.84 % -25.99 % 29.92 %
Net Income in Millions -1,184 -825 -33 -12 76
Y / Y Net Income Change - - - - 66.65 %
Return On Equity -79.34 % -32.16 % -0.96 % -0.34 % 1.64 %

Back to ENOV Management Effectiveness >> ENOV's 5 Years Annual ROE >> Compare ENOV ROE to its Competitors




More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
ENOV's' Return on Equity at Yahoo Finance
ENOV's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for ENOV's Competitors
Subscribers only: Roe for Enovis's Suppliers
Subscribers only: Return On Equity for ENOV's Customers




Companies with similar Return On Equity at Jul 03 2026, within Healthcare Sector ROE

Date modified: 2026-09-12T06:12:02+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.